Recombinant Escherichia phage P1 cre Protein ，His & Myc

The research on Cre recombinase (Cre) proteins stems from their pivotal role in genetic engineering, particularly in the manipulation of DNA sequences within organisms. Discovered in the early 1980s, Cre, derived from the P1 bacteriophage, functions as a site-specific recombinase that recognizes loxP sites—short DNA sequences that enable the precise excision or insertion of genetic material. This capability has transformed numerous fields, including developmental biology, cancer research, and gene therapy, by allowing scientists to create conditional knockout models in mice and other organisms. The ability to control gene expression spatially and temporally has provided invaluable insights into gene function and regulation. Additionally, advancements in Cre technology have led to the development of various Cre-based systems, such as Cre-loxP, which allow for targeted gene activation or repression, enhancing the understanding of complex biological processes. The flexibility and efficiency of Cre recombinase have made it an indispensable tool in modern molecular biology, facilitating breakthroughs in our understanding of genetic elements and their roles in health and disease. As ongoing research continues to optimize Cre functionality and expand its applications, it remains a cornerstone of genetic manipulation techniques, paving the way for novel therapeutic approaches and innovations in synthetic biology.